Concepedia

Ran Liu

RL

Statistics

Publications

50

Citations

2.8K

H-Index

27

Active since

2011

Affiliations

Shenyang Pharmaceutical University(Current)

AbbVie (United States)

Southern California Reproductive Center

Texas Liver Institute

The University of Texas at San Antonio Health Science Center

Ran Liu is an author at Shenyang Pharmaceutical University specializing in pharmacy, pharmacology, and chromatographic analysis.

ORCID

Publications per year

2011–2024

50

Publications

50

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Stefan Zeuzem, Graham R. Foster, Stanley Wang et al. · New England Journal of Medicine · 2018 · 437 citations · Full text

, , +17

Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis

Paul Y. Kwo, Fred Poordad, Armen Asatryan et al. · Journal of Hepatology · 2017 · 297 citations · Full text

, , +16

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Tarik Asselah, Kris V. Kowdley, Neddie Zadeikis et al. · Clinical Gastroenterology and Hepatology · 2017 · 230 citations · Full text

, , +17

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

William D. Schlaff, Ronald Ackerman, Ayman Al‐Hendy et al. · New England Journal of Medicine · 2020 · 200 citations

, , +17

Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial

David Wyles, Fred Poordad, Stanley Wang et al. · Hepatology · 2017 · 146 citations · Full text

, , +17

1–5 of 50